| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150.2M | -6.5% | +0.2% |
| Cost of Revenue | $65.9M | -5.7% | +5.9% |
| Gross Profit | $84.2M | -7.0% | -3.9% |
| R&D Expense | $2.3M | +9.5% | +0.0% |
| SG&A Expense | $75.0M | +4.0% | +4.5% |
| Operating Income | -$15.8M | -79.1% | -104.6% |
| Pre-tax Income | -$15.6M | -78.8% | -122.1% |
| Income Tax | -$5.0M | -143.5% | -141.3% |
| Net Income | -$10.6M | -58.7% | -114.0% |
| EPS (Basic) | -$0.72 | -60.0% | -125.0% |
| EPS (Diluted) | -$0.72 | -60.0% | -125.0% |
| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.7M | -30.6% | -61.5% |
| Accounts Receivable | $17.0M | +20.5% | +5.2% |
| Current Assets | $186.0M | -2.0% | -11.4% |
| Total Assets | $495.5M | +0.4% | -0.8% |
| Current Liabilities | $137.0M | +9.5% | -2.9% |
| Total Liabilities | $306.2M |
| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.1M | — | — |
| Capital Expenditures | $18.2M | — | — |
| Investing Cash Flow | -$18.7M | — | — |
| Financing Cash Flow | -$7.2M | — | — |
| Free Cash Flow | -$52.3M | — | — |
| +1.0% |
| Stockholders' Equity | $189.3M | -4.1% | -3.7% |